{
    "organizations": [],
    "uuid": "053033215ed0c235af04039cf1c3a2af62ce35be",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-molecular-partners-partner-allerga/brief-molecular-partners-partner-allergan-exercises-third-option-for-darpin-product-candidate-in-ophthalmology-idUSFWN1Q900L",
    "ord_in_thread": 0,
    "title": "BRIEF-Molecular Partners' Partner Allergan Exercises Third Option For Darpin Product Candidate In Ophthalmology",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 19 (Reuters) - MOLECULAR PARTNERS AG:\n* MOLECULAR PARTNERSâ€™ PARTNER ALLERGAN EXERCISES THIRD OPTION FOR DARPIN PRODUCT CANDIDATE IN OPHTHALMOLOGY Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-02-19T14:11:00.000+02:00",
    "crawled": "2018-02-20T14:13:35.044+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "molecular",
        "partner",
        "ag",
        "molecular",
        "partner",
        "partner",
        "allergan",
        "exercise",
        "third",
        "option",
        "darpin",
        "product",
        "candidate",
        "ophthalmology",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}